92062 ⎘
Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS
#2POLYMERIC (METH)ACRYLATE PHOTOINITIATORS
#3INHIBITORS OF THE ONCOGENIC SHP2 PHOSPHATASE AND USES THEREOF
#4TARGETED CONTRAST AGENTS FOR MRI OF ALPHA-SYNUCLEIN DEPOSITION
#5LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS
#6Targeted contrast agents for MRI of alpha-synuclein deposition
#7Compound for modulating DDAH and ADMA levels, as well as methods of using thereof to treat disease
#8Compounds having excited state intramolecular proton transfer (ESIPT) character for use in treating and/or preventing sunburn and/or preventing U.V. damage
#9TARGETED CONTRAST AGENTS FOR MRI OF ALPHA-SYNUCLEIN DEPOSITION
#10Lanthionine synthetase C-like 2-based therapeutics
#11Compound for modulating DDAH and ADMA levels, as well as methods of using thereof to treat disease
#12Lanthionine synthetase C-like 2-based therapeutics
#13Lanthionine synthetase C-like 2-based therapeutics
#14Ester compound and PIN1 inhibitor, inflammatory disease therapeutic, and colon cancer therapeutic in which said ester compound is used
#15Deoxybenzoin monomers and branched polymers prepared therefrom
#16Lanthionine synthetase C-like 2-based therapeutics
#17Lanthionine synthetase C-like 2-based therapeutics
#18Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof
#19Method for the preparation of Intermediates for carboxy-fluoresceins and novel carboxy-fluorescein
#20Compound having higher inhibitory activity on protein kinase G and preparation method thereof
#21Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof
#22Lanthionine synthetase C-like 2-based therapeutics
#23Active material, and sodium ion battery and lithium ion battery using the same
#24Monomer for hardmask composition, hardmask composition including said monomer, and method for forming pattern using said hardmask composition
#25Therapeutic agents
#26Small molecule inhibitors of the pleckstrin homology domain and methods for using same
#27Therapeutic agents
#28SALTS OF FENOFIBRIC ACID AND PHARMACEUTICAL FORMULATIONS THEREOF
#29COMPOSITIONS AND METHODS TO TREAT DISEASE CHARACTERIZED BY CELLULAR PROLIFERATION AND ANGIOGENESIS
#30Compounds and Mixtures Influencing Inflammatory States
#31Compounds and mixtures for influencing inflammatory states
#32Small-molecule-targeted protein degradation
#33Small molecule inhibitors of the pleckstrin homology domain and methods for using same
#34Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA
#35Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA
#36Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA
#37SALTS OF FENOFIBRIC ACID AND PHARMACEUTICAL FORMULATIONS THEREOF
#38BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS
#39Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders
#40Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA
#41METHODS TO RADIOLABEL NATURAL ORGANIC MATTER BY REDUCTION WITH HYDROGEN LABELED REDUCING AGENTS
#42Small molecule inhibitors of the pleckstrin homology domain and methods for using same
#43SUBSTITUTED 2-NAPHTHOIC ACIDS AS ANTAGONISTS OF GPR105 ACTIVITY
#44BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION
#45Method for production of 3-hydroxypropan-1-one compound, method for production of 2-propen-1-one compound and method for production of isoxazoline compound
#46BIARYL PDE4 INHIBITORS FOR TREATING INFLAMMATORY, CARDIOVASCULAR AND CNS DISORDERS
#47SALTS OF FENOFIBRIC ACID AND PHARMACEUTICAL FORMULATIONS THEREOF
#48Vitamin D receptor modulators
#49Vitamin D receptor modulators
#50Benzoic Acid Derivatives that are Modulators or Agonists of GlyR
#51BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS
#52NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF
#53Vitamin D receptor modulators
#54Indanone Potentiators of Metabotropic Glutamate Receptors
#55Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
#56Methods to radiolabel natural organic matter by reduction with hydrogen labeled reducing agents
#57Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
#58THERAPEUTIC COMPOUNDS
#59Benzene compound having 2 or more substituents
#60Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
#61Diaminopropionic acid derivatives
#62Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
#63KCNQ channel modulating compounds and their pharmaceutical use
#64Carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia
#65Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
#66Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto
#67Process for preparing pentacene derivatives
#68Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA
#69Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
#70Benzenedicarboxylic acid derivatives
#71Ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof
#72Ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof
#73Benzophenone derivatives or salts thereof
#74Diaminopropionic acid derivatives
#75Antimicrobials from an epigenetics based fungal metabolite screening program
#76Antimicrobials from an epigenetics based fungal metabolite screening program
#77Antimicrobials from an epigenetics based fungal metabolite screening program